Open access peer-reviewed chapter

AAV Biology, Infectivity and Therapeutic Use from Bench to Clinic

By Melisa A. Vance, Angela Mitchell and Richard J. Samulski

Submitted: November 12th 2014Reviewed: November 11th 2015Published: November 26th 2015

DOI: 10.5772/61988

Downloaded: 2507

© 2015 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Melisa A. Vance, Angela Mitchell and Richard J. Samulski (November 26th 2015). AAV Biology, Infectivity and Therapeutic Use from Bench to Clinic, Gene Therapy - Principles and Challenges, Doaa Hashad, IntechOpen, DOI: 10.5772/61988. Available from:

chapter statistics

2507total chapter downloads

9Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

First Insights into Non-invasive Administration Routes for Non-viral Gene Therapy

By Ilia Villate-Beitia, Gustavo Puras, Jon Zarate, Mireia Agirre, Edilberto Ojeda and Jose Luis Pedraz

Related Book

First chapter

Association of COX-2 Promoter Polymorphism with Gastroesophageal Reflux Disease (GERD) and Gastrointestinal Cancers from Iran: An Application for the Design of Early Detection of Cancer and Providing Prognostic Information to Patients in a Clinical Settin

By Firouzeh Biramijamal

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us